Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Impedimed Limited ( (AU:IPD) ) has issued an announcement.
ImpediMed Limited has secured a US$15 million growth capital facility from SWK Funding LLC to support its strategic growth and commercialization activities. This financing provides ImpediMed with the financial flexibility needed to execute its business plan and capitalize on market opportunities, positioning the company for long-term success and value creation for shareholders.
More about Impedimed Limited
ImpediMed Limited operates in the healthcare industry, focusing primarily on digital health technologies. The company’s flagship product, the SOZO digital health platform, is designed to revolutionize the way clinicians assess and manage fluid and body composition, enhancing patient outcomes.
YTD Price Performance: -10.0%
Average Trading Volume: 33,136
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $64.61M
See more data about IPD stock on TipRanks’ Stock Analysis page.
